CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 90 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $5,000 | – | 485 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 3,917,622 | $7,365,000 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 54,092 | $102,000 | 0.06% |
| Carmignac Gestion | 1,937,608 | $3,643,000 | 0.05% |
| OXFORD FINANCIAL GROUP, LTD. LLC | 91,824 | $173,000 | 0.03% |
| SIGNATUREFD, LLC | 121,351 | $228,000 | 0.01% |
| Tekla Capital Management LLC | 165,330 | $311,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 184,000 | $346,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 567,903 | $1,068,000 | 0.01% |
| Integrated Advisors Network LLC | 15,700 | $30,000 | 0.00% |
| WEDBUSH SECURITIES INC | 22,900 | $43,000 | 0.00% |